Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow lsa Template on Twitter
Research Article
Source Data
Transparent Process
Open Access

Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy

Emma V Rusilowicz-Jones, View ORCID ProfileFrancesco G Barone, Fernanda Martins Lopes, Elezabeth Stephen, View ORCID ProfileHeather Mortiboys, Sylvie Urbé  Correspondence email, View ORCID ProfileMichael J Clague  Correspondence email
Emma V Rusilowicz-Jones
1Department of Molecular Physiology and Cell Signaling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK
Roles: Conceptualization, Data curation, Formal analysis, Investigation, Funding acquisition, Methodology, Writing—original draft, review, and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco G Barone
1Department of Molecular Physiology and Cell Signaling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK
Roles: Conceptualization, Data curation, Formal analysis, Investigation, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Francesco G Barone
Fernanda Martins Lopes
2Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK
Roles: Formal analysis, Investigation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elezabeth Stephen
2Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK
Roles: Formal analysis, Investigation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Mortiboys
2Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK
Roles: Conceptualization, Supervision, Funding acquisition, Project administration, Writing—review and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heather Mortiboys
Sylvie Urbé
1Department of Molecular Physiology and Cell Signaling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK
Roles: Conceptualization, Supervision, Funding acquisition, Visualization, Project administration, Writing—original draft, review, and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: urbe@liv.ac.uk
Michael J Clague
1Department of Molecular Physiology and Cell Signaling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK
Roles: Conceptualization, Supervision, Funding acquisition, Project administration, Writing—original draft, review, and editing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J Clague
  • For correspondence: clague@liv.ac.uk
Published 29 November 2021. DOI: 10.26508/lsa.202101287
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. CMPD-39 is a selective USP30 inhibitor.

    (A) Chemical structure of CMPD-39. (B) DUB specificity screen (DUB profiler, Ubiquigent) with 1-100 μM CMPD-39. (C) Activity-based ubiquitin probe assay shows that CMPD-39 engages USP30 in cells at nanomolar concentrations in intact SHSY5Y cells. Samples were incubated with CMPD-39 for 2 h at the indicated concentrations, then incubated with HA-Ub-PA probe for 10 min at 37°C and immunoblotted as shown. Red arrow indicates unbound USP30; blue arrow represents probe bound USP30. (D) Inhibition of USP30 enhances the ubiquitylation of TOMM20 in YFP-PRKN over-expressing hTERT-RPE1 cells in a concentration dependent manner in response to mitophagy induction. Cells were treated for 1 h with DMSO or antimycin A and oligomycin A (AO; 1 μM each) in the absence or presence of CMPD-39 at the indicated concentrations, lysed, and analyzed by Western blotting. Black arrow indicates unmodified TOMM20, ubiquitylated species are indicated by red (mono-ubiquitylated) or blue arrow heads. Quantitation shows percentage mono-ubiquitylated.

    Source data are available for this figure.

    Source Data for Figure 1[LSA-2021-01287_SdataF1.xlsx]

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. CMPD-39 promotes depolarization-dependent ubiquitylation of previously described USP30 substrates.

    (A) USP30 inhibitor (CMPD-39) treatment of Parental (PAR) hTERT-RPE1-YFP-PRKN cells phenocopies USP30 deletion (KO1E) by promoting TOMM20 degradation, whereas TOMM20 degradation is unaffected by CMPD-39 in the USP30 KO (KO1E) cells. Cells were treated for 4 h ± AO (1 μM) ± 200 nM CMPD-39. (B) TOMM20 and SYNJ2BP ubiquitylation is enhanced within 1 h by CMPD-39 but is unaffected in the USP30 KO (KO1E) cells. Cells were treated for 1 h ± AO (1 μM) ± 200 nM CMPD-39. (C, D) Graphs show quantification of mono-ubiquitylated TOMM20 and SYNJ2BP in AO-treated samples as a percentage of total for two independent experiments (error bars indicate the range). (E) USP30 inhibitor (CMPD-39) treatment of cells expressing endogenous PRKN (SHSY5Y cells) similarly phenocopies USP30 deletion (KO11) by promoting TOMM20 and SYNJ2BP ubiquitylation, as well as increasing levels of phospho-Ser65 Ubiquitin (pUb). Cells were treated for 4 h ± AO (1 μM) in the absence or presence of 1 μM CMPD-39. (E, F, G) Graphs show quantification of AO treated samples for mono-ubiquitylated TOMM20 as a percentage of total TOMM20 (F) and the pUb signal normalised to AO treated SHSY5Y cells (G) in the 38–76 kD range, for two independent experiments represented by (E) (error bars indicate the range). (B, E): Black arrow indicates unmodified species, and red and blue arrow heads indicate the mono- and multi-ubiquitylated species, respectively.

    Source data are available for this figure.

    Source Data for Figure 2[LSA-2021-01287_SdataF2.1.xlsx][LSA-2021-01287_SdataF2.2.pdf][LSA-2021-01287_SdataF2.3.pdf]

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Enhancement of basal mitophagy by pharmacological inhibition of USP30.

    (A) Representative images of SHSY5Y-mitoQC cells. Cells were treated with DMSO or CMPD-39 (200, 500, or 1,000 nM) for 96 h before imaging. Scale bar 20 μm. (B, C) Quantification of the data from three independent experiments is shown. Median and interquartile range are indicated; 65 cells were quantified per condition. (B) Graph illustrates the number of mitolysosomes. **P < 0.01, One-way ANOVA with Dunnett’s multiple comparisons test. (C) Graph shows the mean mitolysosome area per cell. *P < 0.05, **P < 0.01, one-way ANOVA with Dunnett’s multiple comparisons test. (D) Mitophagy index for patient derived dopaminergic iNeurons derived from two control individuals and two individuals with PRKN loss of function mutations. CMPD-39 was administered for 24 h before measurement. Error bars indicate SEM. Two-way ANOVA with Tukey’s multiple-comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (E) Mitochondrial membrane potential in dopaminergic neurons derived from control and PRKN patients. CMPD-39 was administered for 24 h before measurement. Error bars indicate SEM. Data are normalised to gender matched untreated control. Statistical analysis was conducted on raw non-normalised data using Mixed effect analysis with Tukey’s multiple-comparisons test. *P < 0.05, **P < 0.01.

    Source data are available for this figure.

    Source Data for Figure 3[LSA-2021-01287_SdataF3.xlsx]

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. Enhancement of basal pexophagy by pharmacological inhibition of USP30.

    (A) Representative images of U2OS-Keima-SKL cells. Cells were treated with DMSO or CMPD-39 (200, 500 or 1,000 nM) for 96 h before imaging. Scale bar 20 μm. (B, C) Quantification of the data is derived from three independent experiments. Median and interquartile range are indicated; 85 cells were quantified per condition. (B) Graph indicates the number of pexolysosomes in U2OS-Keima-SKL cells. One-way ANOVA with Dunnett’s multiple comparisons test, ****P < 0.0001. (C) Graph indicates the mean pexolysosome area per cell. One-way ANOVA with Dunnett’s multiple-comparisons test, ****P < 0.0001.

    Source data are available for this figure.

    Source Data for Figure 4[LSA-2021-01287_SdataF4.xlsx]

PreviousNext
Back to top
Download PDF
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Benchmarking a USP30 inhibitor
Emma V Rusilowicz-Jones, Francesco G Barone, Fernanda Martins Lopes, Elezabeth Stephen, Heather Mortiboys, Sylvie Urbé, Michael J Clague
Life Science Alliance Nov 2021, 5 (2) e202101287; DOI: 10.26508/lsa.202101287

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Benchmarking a USP30 inhibitor
Emma V Rusilowicz-Jones, Francesco G Barone, Fernanda Martins Lopes, Elezabeth Stephen, Heather Mortiboys, Sylvie Urbé, Michael J Clague
Life Science Alliance Nov 2021, 5 (2) e202101287; DOI: 10.26508/lsa.202101287
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
Issue Cover

In this Issue

Volume 5, No. 2
February 2022
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Cell Biology

Related Articles

  • No related articles found.

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Regulation of survival of C. elegans by amphid neurons
  • Genome-wide modeling of fly metabolism
  • Modeling IPF in iPSC-derived alveolar organoids
Show more Research Article

Similar Articles

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2023 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.